Daniel, Justin Kirby .
HRN: 22-63-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/01/2023
09/07/2023
IVT
340mg
Q6
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes